Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database

被引:100
|
作者
Baron, Murray [1 ,2 ]
Hudson, Marie [1 ,2 ]
Steele, Russell [1 ,2 ]
机构
[1] SMBD Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
MALNUTRITION; SYSTEMIC SCLEROSIS; RISK FACTORS; QUALITY-OF-LIFE; UNIVERSAL SCREENING TOOL; NUTRITIONAL ASSESSMENT; BACTERIAL OVERGROWTH; DIETARY-INTAKE; BOWEL; HYPERALIMENTATION; CLASSIFICATION; COMPLICATIONS; INVOLVEMENT;
D O I
10.3899/jrheum.090694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis (SSc) is a multisystem disease associated with significant morbidity and increased mortality. Little is known about nutritional status in SSc. We investigated the prevalence and demographic and clinical correlates of nutritional status in a large cohort of patients with SSc. Methods. This was a cross-sectional multicenter Study of patients (n = 586) from the Canadian Scleroderma Research Group Registry. Patients were assessed with detailed clinical histories, medical examinations, and self-administered questionnaires. The primary outcome was risk for malnutrition using the "malnutrition universal screening tool" (MUST). Multiple logistic regression was used to assess the relationship between selected demographic and clinical variables and MUST categories. Results. Of the 586 patients in the study, MUST scores revealed that almost 18% were at high risk for malnutrition. The significant correlates of high malnutrition risk included the number of gastrointestinal (GI) complaints, disease duration, diffuse disease, physician global assessment of disease severity, hemoglobin, oral aperture, abdominal distension on physical examination, and physician-assessed possible malabsorption. Among 14 GI symptoms, only poor appetite and lack of a history of abdominal swelling and bloating predict MUST. These factors accounted for 24% of the variance in MUST scores. Conclusion. The risk for malnutrition in SSc is moderate and is associated with shorter disease duration, markers of GI involvement, and disease severity. Patients with SSc should be screened for malnutrition. and potential underlying causes assessed and treated when possible. (First Release Oct 15 2009; J Rheumatol 2009;36:2737-43 doi: 10.3899/jrheum.090694)
引用
收藏
页码:2737 / 2743
页数:7
相关论文
共 50 条
  • [41] Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
    Avouac, J.
    Fransen, J.
    Walker, U. A.
    Riccieri, V.
    Smith, V.
    Muller, C.
    Miniati, I.
    Tarner, I. H.
    Bellando Randone, S.
    Cutolo, M.
    Allanore, Y.
    Distler, O.
    Valentini, G.
    Czirjak, L.
    Mueller-Ladner, U.
    Furst, D. E.
    Tyndall, A.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) : 476 - 481
  • [42] Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population
    Sobchak, Curtis
    Beattie, Karen
    Larche, Maggie
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 778 - 778
  • [43] Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population
    Sobchak, Curtis
    Beattie, Karen
    Larche, Maggie
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3880 - 3881
  • [44] Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
    Tyndall, Anthony J.
    Bannert, Bettina
    Vonk, Madelon
    Airo, Paolo
    Cozzi, Franco
    Carreira, Patricia E.
    Bancel, Dominique Farge
    Allanore, Yannick
    Mueller-Ladner, Ulf
    Distler, Oliver
    Iannone, Florenzo
    Pellerito, Raffaele
    Pileckyte, Margarita
    Miniati, Irene
    Ananieva, Lidia
    Gurman, Alexandra Balbir
    Damjanov, Nemanja
    Mueller, Adelheid
    Valentini, Gabriele
    Riemekasten, Gabriela
    Tikly, Mohammed
    Hummers, Laura
    Henriques, Maria J. S.
    Caramaschi, Paola
    Scheja, Agneta
    Rozman, Blaz
    Ton, Evelien
    Kumanovics, Gabor
    Coleiro, Bernard
    Feierl, Eva
    Szucs, Gabriella
    Von Muehlen, Carlos Alberto
    Riccieri, Valeria
    Novak, Srdan
    Chizzolini, Carlo
    Kotulska, Anna
    Denton, Christopher
    Coelho, Paulo C.
    Koetter, Ina
    Simsek, Ismail
    de la Pena Lefebvre, Paloma Garcia
    Hachulla, Eric
    Seibold, James R.
    Rednic, Simona
    Stork, Jiri
    Morovic-Vergles, Jadranka
    Walker, Ulrich A.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) : 1809 - 1815
  • [45] Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
    Allanore, Y.
    Meune, C.
    Vonk, M. C.
    Airo, P.
    Hachulla, E.
    Caramaschi, P.
    Riemekasten, G.
    Cozzi, F.
    Beretta, L.
    Derk, C. T.
    Komocsi, A.
    Farge, D.
    Balbir, A.
    Riccieri, V.
    Distler, O.
    Chiala, A.
    Del Papa, N.
    Simic, K. Pasalic
    Ghio, M.
    Stamenkovic, B.
    Rednic, S.
    Host, N.
    Pellerito, R.
    Zegers, E.
    Kahan, A.
    Walker, U. A.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 218 - 221
  • [46] Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
    Jordan, Suzana
    Distler, Joerg H. W.
    Maurer, Britta
    Huscher, Doerte
    van Laar, Jacob M.
    Allanore, Yannick
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1188 - 1194
  • [47] Effects and Safety of Rituximab in Systemic Sclerosis: An Analysis From the European Scleroderma Trial and Research Group.
    Jordan, Suzana
    Distler, Jorg H. W.
    Maurer, Britta
    Van Laar, Jacob M.
    Allanore, Yannick
    Distler, Oliver
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S272 - S273
  • [48] EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
    Kowal-Bielecka, O.
    Landewe, R.
    Avouac, J.
    Chwiesko, S.
    Miniati, I.
    Czirjak, L.
    Clements, P.
    Denton, C.
    Farge, D.
    Fligelstone, K.
    Foeldvari, I.
    Furst, D. E.
    Mueller-Ladner, U.
    Seibold, J.
    Silver, R. M.
    Takehara, K.
    Toth, B. Garay
    Tyndall, A.
    Valentini, G.
    van den Hoogen, F.
    Wigley, F.
    Zulian, F.
    Matucci-Cerinic, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 620 - 628
  • [49] NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group
    Jha, Mayank
    Wang, Mianbo
    Steele, Russell
    Baron, Murray
    Fritzler, Marvin J.
    Hudson, Marie
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (01) : 62 - 70
  • [50] Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database
    Mongin, Denis
    Matucci-Cerinic, Marco
    Walker, Ulrich A.
    Distler, Oliver
    Becvar, Radim
    Siegert, Elise
    Ananyeva, Lidia P.
    Smith, Vanessa
    Alegre-Sancho, Juan Jose
    Yavuz, Sule
    Limonta, Massimiliano
    Riemekasten, Gabriela
    Rezus, Elena
    Vonk, Madelon
    Truchetet, Marie-Elise
    Del Galdo, Francesco
    Courvoisier, Delphine S.
    Iudici, Michele
    EUSTAR Collaborators
    ARTHRITIS CARE & RESEARCH, 2025,